Search results
Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug
Investor's Business Daily· 4 months agoViking Therapeutics moved up its timeline for an Eli Lilly-rivaling obesity treatment on Thursday....
Zacks Investment Ideas feature highlights: SPDR S&P Biotech ETF, iShares Biotech ETF, Viking...
Zacks via Yahoo Finance· 3 months agoFor Immediate Release Chicago, IL – April 1, 2024 – Today, Zacks Investment Ideas feature highlights...
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Zacks via Yahoo Finance· 3 months agoIt was a busy week for the biotech sector, with lots of study data readouts and regulatory updates....
Top 1% Biotech Viking Yo-Yos, But Hits A Record, On NASH Enthusiasm
Investor's Business Daily· 1 year agoViking Therapeutics unveiled promising test results Tuesday for a liver disease treatment, and VKTX...
3 Underappreciated Stocks with Triple-Digit Upside: May 2024
InvestorPlace via Yahoo Finance· 2 weeks agoThere are plenty of underappreciated stocks on the market. Look at Viking Therapeutics...
3 Biotech Stocks to Buy on the Dip: March 2024
InvestorPlace via Yahoo Finance· 3 months agoOne of the best dip-buying opportunities in biotech stocks to buy was in Viking Therapeutics (NASDAQ:VKTX). After hitting a high of $99.41, VKTX dipped...
Is It Too Late to Buy Viking Therapeutics Stock?
Motley Fool via Yahoo Finance· 3 months agoViking Therapeutics (NASDAQ: VKTX) has emerged this year as a formidable contender in the increasingly popular anti-obesity market. While it doesn't have...
This High-Flying Stock Just Announced More Good News: Time to Buy?
Motley Fool via Yahoo Finance· 1 week agoThe biotech industry features many prominent companies that command plenty of attention on the...
Is Viking Therapeutics Stock a Buy?
Motley Fool via Yahoo Finance· 3 months agoWith Viking Therapeutics (NASDAQ: VKTX) stock exploding skyward by 528% over the last 12 months, it's easy to wonder if the opportunity to buy its stock...
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Zacks via Yahoo Finance· 1 month agoViking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous...
